Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

These companies focused as much on cod liver ... Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.

As the industry advances ... Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. Waleed Zafar is the mission critical ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Andre Bryan is using the zones to take his business to the next level, and he wants other Black founders to rise with him.

Mass layoffs at the FDA, including senior negotiators, have disrupted the process of reauthorizing user fee programs that ...

Pfizer, Novartis, Amgen, Eli Lilly and J&J lead pharma lobbying spend amid policy changes. Issues include 340B program, drug ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current ...